Jupiter Research Capital (Asia) Ltd’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$220K Buy
+583
New +$203K 0.02% 575
2026
Q2
– Sell
-8,871
Closed -$2.47M – 754
2026
Q1
$2.47M Buy
+8,871
New +$2.55M 0.27% 84

Other funds holding BIO

Jupiter Research Capital (Asia) Ltd's BIO Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 583 shares worth $220K. The stake represents 0.02% of the portfolio and ranks #575 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in BIO as recently as Q1 2026.

Jupiter Research Capital (Asia) Ltd first reported a position in BIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.47M in Q1 2026. 405 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 583 shares of Bio-Rad Laboratories Class A worth $220K as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.02% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #575 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and has held it in 2 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Bio-Rad Laboratories Class A position peaked at $2.47M in Q1 2026.
  • 405 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.